A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial.

OBJECTIVES The purpose of this study was to evaluate whether the addition of a contrast agent to dobutamine stress echocardiography (DSE) improves its diagnostic accuracy for coronary artery disease (CAD) and to determine the effect of image quality on the diagnostic impact of contrast agent use in this setting. BACKGROUND Contrast agents can improve endocardial border definition. To date, however, there are no randomized trials that have evaluated the impact of contrast agent use on the accuracy of DSE. METHODS Patients referred for stress testing with dobutamine echocardiography underwent 2 DSE studies: 1 with and 1 without a contrast agent, at least 4 h apart in a randomized order and within a 24-h period. RESULTS A total of 101 patients underwent both DSE studies. Similar hemodynamics were achieved during the 2 stress testing sessions. The use of a contrast agent improved the percentage of segments adequately visualized at baseline (from 72 +/- 24% to 95 +/- 8%) and more so at peak stress (67 +/- 28% to 96 +/- 7%); both p < 0.001. Interpretation of wall motion with high confidence also increased with contrast agent use from 36% to 74% (p < 0.001). Segment visualization with the use of a contrast agent improved in all views, but was more pronounced in the apical views. In unenhanced DSE, 36% of studies were normal, 51% had ischemia, and 8% were uninterpretable-all of which became interpretable with the use of a contrast agent. When compared with angiography (n = 92; 55 patients with CAD), accurate detection of ischemia was higher with contrast-enhanced studies versus nonenhanced studies (p = 0.02). As endocardial visualization and confidence of interpretation decreased in unenhanced studies, a greater impact of the use of a contrast agent on DSE accuracy was observed (p < 0.01). CONCLUSIONS During dobutamine stress echocardiography, contrast agent administration improves endocardial visualization at rest and more so during stress, leading to a higher confidence of interpretation and greater accuracy in evaluating CAD. The lesser the endocardial border visualization, the higher the impact of contrast echocardiography on accuracy.

[1]  K. Schechtman,et al.  Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. , 2001, The American journal of cardiology.

[2]  William A Zoghbi,et al.  Stress echocardiography: current methodology and clinical applications. , 2005, Journal of the American College of Cardiology.

[3]  M. Verani,et al.  Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. , 1998, Circulation.

[4]  T. Porter,et al.  Improved Endocardial Border Resolution During Dobutamine Stress Echocardiography with Intravenous Sonicated Dextrose Albumin , 1994, Journal of the American College of Cardiology.

[5]  K. Kuntz,et al.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. , 1998, JAMA.

[6]  H. Becher,et al.  Safety of contrast dobutamine stress echocardiography: a single center experience. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  P. Pellikka,et al.  Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  R M Peshock,et al.  Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. , 1998, Journal of the American College of Cardiology.

[9]  J. Seward,et al.  Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. , 1997, Circulation.

[10]  Julio E. Pérez,et al.  Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders. , 1995, American heart journal.

[11]  J G Miller,et al.  Contrast Echocardiography: Current and Future Applications , 2000 .

[12]  M. Kern,et al.  Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. , 2001, American heart journal.

[13]  J. Seward,et al.  Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. , 1995, Mayo Clinic proceedings.

[14]  T R Porter,et al.  Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. , 1994, Journal of the American College of Cardiology.

[15]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[16]  F. Pashkow,et al.  Accuracy and limitations of exercise echocardiography in a routine clinical setting. , 1992, Journal of the American College of Cardiology.

[17]  J. Gottdiener,et al.  Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. , 2000, The American journal of cardiology.

[18]  G. Minardi,et al.  Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. , 2002, European heart journal.

[19]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  J. Seward,et al.  Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. , 1998, Circulation.

[21]  D. Bach,et al.  False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. , 1994, Journal of the American College of Cardiology.

[22]  T. Irvine,et al.  Dobutamine stress echocardiography: improved endocardial border definition and wall motion analysis with tissue harmonic imaging. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.